Alpa Laboratories is a domestic pharma company involved in the manufacturing and marketing of formulations. Its product portfolio contains ethical drugs, OTC drugs as well as veterinary products. It is a WHO-GMP and ISO 9001:2000 Certified company with a total built up area of 1,10,000 sq.ft.
Alpa Laboratories Ltd. has entered with couple of international companies to expands its product portfolio distribution on global level. The recent of the deals is appointment of Vhermann Pharmaceuticals of Philippines as a distributor for its products already registered in Philippines.Alpa has also appointed Tinez Pharmaceuticals Ltd. of Nigeria to distribute its products in Nigeria.
Bihar Government has allocated thirteen locations for setting up Generic Drugs Retail Outlets. Company expects to notch up revenue of around Rs.80m and bottomline at Rs.20 mn. This development was under the initiative of State Health Society.
Alpa has garnered sales of Rs.449m, which is better by 49% on YoY basis. EBITDA has also increased by 48% YoY at Rs.416m where the margin has also improved by 100bps due to relatively low rise in the overall cost. Capex of the company by the end of this quarter was Rs.194m. Its bottomline has increased by 83% YoY due to low depreciation. The stock is currently trading 9x its annualized Q2FY08 EPS of Rs.4.9.